159 related articles for article (PubMed ID: 5883516)
1. Laboratory and clinical comparison of cephaloridine and cephalothin.
Benner EJ; Brodie JS; Kirby WM
Antimicrob Agents Chemother (Bethesda); 1965; 5():888-93. PubMed ID: 5883516
[No Abstract] [Full Text] [Related]
2. In vitro comparison of cefazolin with other cephalosporins.
Yeivin R; Meshulam M; Sacks T
Isr J Med Sci; 1974 Sep; 10(9):1092-5. PubMed ID: 4436031
[No Abstract] [Full Text] [Related]
3. [Antistaphylococcic effect of cephalothin, cephaloridine and cephazoline. I. In vitro activity].
Martinetto P; Savoia D; Cavallo G
G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):374-6. PubMed ID: 5155946
[No Abstract] [Full Text] [Related]
4. Cephaloridine and cephalothin comparative in vitro evaluation.
Perkins RL; Saslaw S; Hackett J
Am J Med Sci; 1967 Mar; 253(3):293-9. PubMed ID: 4381476
[No Abstract] [Full Text] [Related]
5. Laboratory determination of antibiotic susceptibility to ampicillin and cephalothin.
Sherris JC; Rashad AL; Lighthart GA
Ann N Y Acad Sci; 1967 Sep; 145(2):248-67. PubMed ID: 4935172
[No Abstract] [Full Text] [Related]
6. Klebsiella, Enterobacter, and Serratia: biochemical differentiation and susceptibility to ampicillin and three cephalosporin derivatives.
Zabransky RJ; Hall JW; Day FE; Needham GM
Appl Microbiol; 1969 Aug; 18(2):198-203. PubMed ID: 4896880
[TBL] [Abstract][Full Text] [Related]
7. [Study on the dynamics of antimicrobial agents in vivo--cephaloridine and cephalothin].
Kitamoto O; Fukaya K; Wajima T
J Antibiot B; 1965 Dec; 18(6):443-6. PubMed ID: 5296407
[No Abstract] [Full Text] [Related]
8. [Basic and clinical evaluation of cephaloridine and cephalothin in the field of surgery].
Ishii R; Ishibiki H; Oi H; Tsunekawa Y; Nakamura Y
J Antibiot B; 1965 Dec; 18(6):479-81. PubMed ID: 5296412
[No Abstract] [Full Text] [Related]
9. [Comparison of antibacterial activity of cephapirin with cephalothin and cephaloridine to various pathogenic bacteria recently isolated from clinical materials (author's transl)].
Kosakai N; Oguri T
Jpn J Antibiot; 1974 Apr; 27(2):157-63. PubMed ID: 4211361
[No Abstract] [Full Text] [Related]
10. [Basic study on synthetic cephalosporin C--cephalothin, cephaloridine].
Nakazawa S; Itagaki M; Yokota Y; Emoto E; Amano M
J Antibiot B; 1965 Dec; 18(6):431-8. PubMed ID: 5329714
[No Abstract] [Full Text] [Related]
11. [Antibacterial activity of cephalothin].
Goto S; Kuwabara S
J Antibiot B; 1965 Dec; 18(6):439-42. PubMed ID: 5296406
[No Abstract] [Full Text] [Related]
12. In vitro activity of BL-S217, a new cephalosporin antibiotic.
Casey F; Bodey GP
J Antibiot (Tokyo); 1974 Jul; 27(7):520-4. PubMed ID: 4156357
[No Abstract] [Full Text] [Related]
13. Comparison of the chemotherapeutic and pharmacodynamic activities of cephradine, cephalothin, and cephaloridine in mice.
Miraglia GJ; Renz KJ; Gadebusch HH
Antimicrob Agents Chemother; 1973 Feb; 3(2):270-3. PubMed ID: 4790592
[TBL] [Abstract][Full Text] [Related]
14. [On the testing of staphylococci for resistance to penicillinase-resistant penicillins and cephalosporins].
Kayser FH
Pathol Microbiol (Basel); 1967; 30(3):381-91. PubMed ID: 5182404
[No Abstract] [Full Text] [Related]
15. Cephaloridine, laboratory and clinical evaluation.
Lane RA; Cox F; McHenry M; Quinn EL
Antimicrob Agents Chemother (Bethesda); 1966; 6():88-95. PubMed ID: 5985310
[No Abstract] [Full Text] [Related]
16. Observations on the mode of action of cefoxitin.
Onishi HR; Zimmerman SB; Stapley EO
Ann N Y Acad Sci; 1974 May; 235(0):406-25. PubMed ID: 4604846
[No Abstract] [Full Text] [Related]
17. [On the clinical aspects of cephalosporins. I. Bacteriological section].
Breitfellner G
Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):174-9. PubMed ID: 4895448
[No Abstract] [Full Text] [Related]
18. [Study on synthetic cephalosporin C].
Aoyama S; Moriguchi S; Takano M; Goto Y; Kawaguchi H
J Antibiot B; 1965 Dec; 18(6):450-3. PubMed ID: 5296409
[No Abstract] [Full Text] [Related]
19. [Basic and clinical studies on cephalosporin C antibiotics].
Kawamori Y; Tanaka S; Mitsuse S; Furuta T; Tomimatsu S
J Antibiot B; 1965 Dec; 18(6):447-9. PubMed ID: 5296408
[No Abstract] [Full Text] [Related]
20. Susceptibility of aerobic and anaerobic Gram-negative rods to cefoxitin and related compounds.
Yeivin R; Peretz J; Sacks T
Isr J Med Sci; 1979 Oct; 15(10):856-8. PubMed ID: 521267
[No Abstract] [Full Text] [Related]
[Next] [New Search]
